49 Wealth Management’s AbbVie ABBV Stock Holding History

49 Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Buy	6,359 +326	+5%	+$72.3K	0.1%	55
2025 Q4	$1.38M	Buy	6,033 +380	+7%	+$86.6K	0.11%	55
2025 Q3	$1.31M	Sell	5,653 -1,454	-20%	-$296K	0.12%	49
2025 Q2	$1.32M	Buy	7,107 +497	+8%	+$92.4K	0.14%	46
2025 Q1	$1.38M	Buy	6,610 +1,307	+25%	+$254K	0.17%	49
2024 Q4	$942K	Buy	5,303 +301	+6%	+$55.3K	0.13%	56
2024 Q3	$988K	Buy	5,002 +3,458	+224%	+$645K	0.16%	56
2024 Q2	$263K	Buy	+1,544	New	+$256K	0.05%	123

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

49 Wealth Management's ABBV Position: Q1 2026 in Review

49 Wealth Management increased its AbbVie (ABBV) stake by 5.4% in Q1 2026, buying an estimated $72.3K and bringing the position to 6,359 shares worth $1.38M. The position accounts for 0.1% of the portfolio, ranked #55.

49 Wealth Management first reported a position in ABBV in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.38M in Q1 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

49 Wealth Management held 6,359 shares of AbbVie worth $1.38M as of Q1 2026.
49 Wealth Management bought 326 AbbVie shares in Q1 2026, an estimated $72.3K.
AbbVie made up 0.1% of 49 Wealth Management's portfolio in Q1 2026, its #55 holding.
49 Wealth Management first reported a position in AbbVie in Q2 2024 and has held it in 8 quarters since.
49 Wealth Management's AbbVie position peaked at $1.38M in Q1 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on 49 Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.